The microenvironmental anti-inflammatory properties of bromelain by uncoated cancer cells (depolymerizing MUC-1, fibrin and albumin) through increasing adhesion of lymphocytes to the tumor are thought to expose the tumor to host defense [ 24]. The gene discussed is ALB; the disease is neoplasm.